KALARIS THERAPEUTICS INC (KLRS) Forecast, Price Target & Analyst Ratings

NASDAQ:KLRS • US4829291065

6.57 USD

-0.24 (-3.52%)

Last: Mar 20, 2026, 04:30 PM

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for KALARIS THERAPEUTICS INC (KLRS).

Consensus Price Target

Price Target

$18.97

+ 188.77% Upside

→ Price target details

Next Earnings Forecast

Earnings Estimate

Release Date: May 12, 2026
Period: Q4 / 2025
EPS Estimate: -$0.54
Revenue Estimate

→ Full earnings forecast details

ChartMill Buy Consensus

Rating

85.00%

Weighted Analyst Rating Score

→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target

$18.97

Upside

+ 188.77%

From current price of $6.57 to mean target of $18.97, Based on 12 analyst forecasts

Low

$5.05

Median

$20.40

High

$27.30

Price Target Revisions

1 Month

0.00%

3 Months

9.41%

Price Target Summary

12 Wall Street analysts provided a forecast for the next 12 months for KLRS. The average price target is 18.97 USD. This implies a price increase of 188.77% is expected in the next year compared to the current price of 6.57.

The average price target has been revised upward by 9.41% in the past 3 months.

→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

Analyst Ratings History

Analyst Ratings Consensus

ChartMill Buy Consensus

85.00%

KLRS was analyzed by 12 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about KLRS.

In the previous month the buy percentage consensus was at a similar level.

KLRS was analyzed by 12 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.

→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Date	Firm	Action	From → To
2025-12-23	Chardan Capital	Initiate	Buy
2025-11-03	Citizens	Initiate	Market Outperform
2025-09-03	Raymond James	Initiate	Strong Buy
2025-04-08	William Blair	Initiate	Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date: May 12, 2026
Period: Q4 / 2025
EPS Estimate: -$0.54
Revenue Estimate
Revenue Q2Q: N/A
EPS Q2Q: -624.81%
Number of Analysts: 8

Next Earnings Revisions

Revenue (1 Month)

N/A

Revenue (3 Months)

N/A

EPS (1 Month)

0.00%

EPS (3 Months)

19.88%

Next Earnings Summary

KLRS is expected to report earnings on 5/12/2026. The consensus EPS estimate for the next earnings is -0.54 USD and the consensus revenue estimate is 0 USD.

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

	2018	2019	2020	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Revenue YoY % growth	1.14M	170K -85.09%	-100.00%	390.15K						13.6M	-100.00%	6.656M	22.329M 235.47%	85.803M 284.27%	189.55M 120.91%	396.61M 109.24%
EBITDA YoY % growth	-3.6M	-26.68M -641.11%	-73.44M -167.02%	-166.26M -138.11%	-176.978M -0.50%	-192.667M -5.94%	-70.115M 61.18%	-55.995M 20.14%	-62.525M -11.66%	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT YoY % growth	-3.6M	-26.7M -641.67%	-75.066M -167.08%	-169.409M -138.14%	-184.517M -0.81%	-189.785M -5.72%	-65.032M 69.61%	-49.782M 9.49%	-57.567M -15.64%	-66.352M -15.26%	-122.394M -84.46%	-120.667M 1.41%	-141.723M -17.45%	-165.183M -16.55%	-103.032M 37.63%	35.744M 134.69%
Operating Margin	-315.79%	-15,705.88%	N/A	-43,421.52%	N/A	N/A	N/A	N/A	N/A	-487.88%	N/A	-1,812.90%	-634.70%	-192.51%	-54.36%	9.01%
EPS YoY % growth	N/A	N/A	-105.96	-61.86 40.53%	-52.71 17.88%	-40.96 25.78%	-0.51 98.68%	-3.77 -644.22%	-2.53 32.88%	-1.63 35.41%	-2.54 -55.70%	-1.92 24.55%	-1.97 -2.66%	-2.10 -6.77%	-1.06 49.44%	0.60 156.55%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

	Q4 / 25	Q1 / 26	Q2 / 26	Q3 / 26	Q4 / 26	Q1 / 27	Q2 / 27	Q3 / 27	Q4 / 27	Q1 / 28	Q2 / 28	Q3 / 28
EPS Q2Q % growth	-0.54 -624.81%	-0.64 74.47%	-0.65 -6.93%	-0.64 -0.53%	-0.60 -10.58%	-0.46 28.34%	-0.75 -14.78%	-0.90 -39.99%	-1.05 -75.75%	-1.20 -161.28%	-1.36 -81.06%	-1.50 -67.04%
Revenue Q2Q % growth										N/A	N/A	N/A
EBITDA Q2Q % growth	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Q2Q % growth	-13.706M 29.80%	-14.154M -36.70%	-14.7M -19.94%	-15.282M -19.94%	-15.901M -16.01%	N/A	N/A	N/A	N/A	N/A	N/A	N/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year

-47.76%

EPS Next 5 Year

-30.54%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year

N/A

Revenue Next 5 Year

N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year

N/A

EBIT Next 5 Year

N/A

→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

KALARIS THERAPEUTICS INC / KLRS Forecast FAQ

What is the average price target for KALARIS THERAPEUTICS INC (KLRS) stock?

12 analysts have analysed KLRS and the average price target is 18.97 USD. This implies a price increase of 188.77% is expected in the next year compared to the current price of 6.57.

When does KALARIS THERAPEUTICS INC (KLRS) report earnings?

KALARIS THERAPEUTICS INC (KLRS) will report earnings on 2026-05-12.

What are the consensus estimates for KLRS stock next earnings?

The consensus EPS estimate for the next earnings of KALARIS THERAPEUTICS INC (KLRS) is -0.54 USD and the consensus revenue estimate is 0 USD.

How do analysts rate KALARIS THERAPEUTICS INC (KLRS)?

The consensus rating for KALARIS THERAPEUTICS INC (KLRS) is 85 / 100 . This indicates that analysts generally have a positive outlook on the stock.

Analyst forecast overview

Forecast Snapshot